학술논문
Pulmonary toxicity of antineoplastic therapy.
Document Type
Academic Journal
Author
Kreisman H; Department of Medicine, Sir Mortimer B. Davis-Jewish General Hospital, McGill University, Montreal, Quebec, Canada.; Wolkove N
Source
Publisher: W.B. Saunders Country of Publication: United States NLM ID: 0420432 Publication Model: Print Cited Medium: Print ISSN: 0093-7754 (Print) Linking ISSN: 00937754 NLM ISO Abbreviation: Semin Oncol Subsets: MEDLINE
Subject
Language
English
ISSN
0093-7754
Abstract
Pulmonary toxicity is often encountered in patients receiving antineoplastic therapy. It may produce a wide variety of clinicopathologic syndromes. As new agents are introduced and their adverse effects recognized, clinicians should be ever vigilant about the possibility of pulmonary toxicity.